AE BIOFUELS WKN: A114CC ISIN: US00770K2024 Kürzel: AMTX Forum: Aktien Thema: Hauptdiskussion

 Aemetis, Inc. Common Stock _________ We have entered into an At the Market Issuance Sales Agreement, or the sales agreement, with H.C. Wainwright & Co., LLC, or the distribution agent, dated January 26, 2021, relating to the sale of our common stock offered by this prospectus supplement. In accordance with the terms of the sales agreement, under this prospectus supplement we may offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $84,000,000 from time to time through the distribution agent, acting as our agent. Sales of our common stock, if any, under this prospectus supplement will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. The distribution agent is not required to sell any specific amount, but will act as our distribution agent using commercially reasonable efforts consistent with its normal trading and sales practices. The distribution agent will be entitled to compensation at a commission rate equal to 3.0% of the gross sales price per share sold under the sales agreement. The net proceeds, if any, that we receive from the sales of our common stock will depend on the number of shares actually sold and the offering price for such shares. See “Plan of Distribution” beginning on page S-16 for additional information regarding the compensation to be paid to the distribution agent. In connection with the sale of the common stock on our behalf, the distribution agent will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of the distribution agent will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to the distribution agent with respect to certain liabilities, including liabilities under the Securities Act. You should read this prospectus supplement in conjunction with the accompanying base prospectus, including any supplements and amendments thereto. This prospectus supplement is qualified by reference to the accompanying base prospectus except to the extent that the information in this prospectus supplement supersedes the information contained in the accompanying base prospectus. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the accompanying base prospectus, including any supplements and amendments thereto. Our common stock is listed on The Nasdaq Stock Market under the symbol “AMTX.” On January 25, 2021, the last reported sale price of our common stock on The Nasdaq Stock Market was $8.80 per share

Viel Erfolg an alle die investiert haben. Zum Glück hat mich die Vernunft doch etwas gebremst.

Aber machen seit Jahren Verlust. Angeblich hat Gevo nur ein Zehntel des Umsatzes von Aemetis aber Bewertung ist fast 10x höher. Echt abenteuerlich.

Ja, die ist niedriger. Das war der Grund warum ich hier eingestiegen bin. Hat noch Luft.

Auf fi na nzen Punkt de kriege ich als Umsatz für 2019 202 Millionen angezeigt. Die Marktkapitalisierung beträgt laut Yahoo 192 Mio. Kann das sein? Dass die Marktkapitalisierung niedriger ist als der Umsatz? Sehe sowas zum ersten mal.

Ist "dass" alles was du zu bieten hast?

, dass

https://youtu.be/thvAy651CSw

Hier sehr interessante presentation von CEO Eric McAffe

Die haben auch in Indien biodiesel plant und letztes Jahr 6 Milionen positive ebit

Zieht jetzt nochmal , power hour

Wichtig ist das Aemetis den Preis für biofuel runter macht und das die 16,8 Milionen richtig verteilen so das man die Produktion Kosten senken kann.

Morgen wird ein guter Tag, heute perfekt gehalten

👌

Das meinte ich aemetis ist mit gevo nicht zu vergleichen, vom biofuel vielleicht schon aber dann hört es schon auf da aemetis viel komplexer aufgestellt ist

Tip top